Clinical trials: Refractory Hypertension or Drug-intolerant Hypertension
Refractory Hypertension or Drug-intolerant Hypertension
Laparoscopic Adventitial Renal Denervation (RDN) for Refractory Hypertension
This is a first-in-human study to test the safety and effectiveness of a new device-based treatment for high blood pressure that is difficult to control with medicine. This condition is known as refractory hypertension.
- Trial name
- NCT07108829
- Testing
- Renal Artery Radiofrequency Ablation Clamp
- Where
- China
- Volunteers
- 10 people
- Sponsor
- Henan Institute of Cardiovascular Epidemiology
Refractory Hypertension or Drug-intolerant Hypertension
Safety and Efficacy of Modulated Ultrasound Renal Denervation for HTN
Prospective, multicenter, randomized, controlled, blinded, and superiority - designed; The target population undergoes a screening treatment with prescribed medications for at least 4 weeks.
- Trial name
- ModulationHTN2 (NCT06877221)
- Testing
- ultrasound renal denervation
- Where
- China
- Volunteers
- 204 people
- Sponsor
- Shenzhen Pulsecare Medical Technology Co., Ltd.